Osteoporosis case finding in the general practice:: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry

被引:9
作者
Gasser, KM
Mueller, C
Zwahlen, M
Kaufmann, M
Fuchs, G
Perrelet, R
Abetel, G
Bürgi, U
Lippuner, K [1 ]
机构
[1] Univ Hosp Bern, Osteoporosis Policlin, CH-3010 Bern, Switzerland
[2] Univ Bern, Dept Social & Prevent Med, Bern, Switzerland
[3] Swiss Fdn Gen Med, Swiss Coll Family Practitioners, Clin Res Grp, Bern, Switzerland
[4] Univ Hosp Bern, Dept Internal Med, CH-3010 Bern, Switzerland
关键词
case finding; DXA; general practice; postmenopausal osteoporosis; radiographic absorptiometry; risk factors;
D O I
10.1007/s00198-005-1846-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mass screening for osteoporosis using DXA measurements at the spine and hip is presently not recommended by health authorities. Instead, risk factor questionnaires and peripheral bone measurements may facilitate the selection of women eligible for axial bone densitometry. The aim of this study was to validate a case finding strategy for postmenopausal women who would benefit most from subsequent DXA measurement by using phalangeal radiographic absorptiometry (RA) alone or in combination with risk factors in a general practice setting. The sensitivity and specificity of this strategy in detecting osteoporosis (T-score <= 2.5 SD at the spine and/or the hip) were compared with those of the current reimbursement criteria for DXA measurements in Switzerland. Four hundred and twenty-three postmenopausal women with one or more risk factors for osteoporosis were recruited by 90 primary care physicians who also performed the phalangeal RA measurements. All women underwent subsequent DXA measurement of the spine and the hip at the Osteoporosis Policlinic of the University Hospital of Berne. They were allocated to one of two groups depending on whether they matched with the Swiss reimbursement conditions for DXA measurement or not. Logistic regression models were used to predict the likelihood of osteoporosis versus "no osteoporosis" and to derive ROC curves for the various strategies. Differences in the areas under the ROC curves (AUC) were tested for significance. In women lacking reimbursement criteria, RA achieved a significantly larger AUC (0.81; 95% CI 0.72-0.89) than the risk factors associated with patients' age, height and weight (0.71; 95% C.I. 0.62-0.80). Furthermore, in this study, RA provided a better sensitivity and specificity in identifying women with underlying osteoporosis than the currently accepted criteria for reimbursement of DXA measurement. In the Swiss environment, RA is a valid case finding tool for patients with risk factors for osteoporosis, especially for those who do not qualify for DXA reimbursement.
引用
收藏
页码:1353 / 1362
页数:10
相关论文
共 47 条
[1]   FACTORS ASSOCIATED WITH APPENDICULAR BONE MASS IN OLDER WOMEN [J].
BAUER, DC ;
BROWNER, WS ;
CAULEY, JA ;
ORWOLL, ES ;
SCOTT, JC ;
BLACK, DM ;
TAO, JL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :657-665
[2]   Hand ultrasound for osteoporosis screening in postmenopausal women [J].
Benitez, CL ;
Schneider, DL ;
Barrett-Connor, E ;
Sartoris, DJ .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 (03) :203-210
[3]   Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial [J].
Black, DM ;
Thompson, DE ;
Bauer, DC ;
Ensrud, K ;
Musliner, T ;
Hochberg, MC ;
Nevitt, MC ;
Suryawanshi, S ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4118-4124
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   Precision and accuracy of computed digital absorptiometry for assessment of bone density of the hand [J].
Bouxsein, ML ;
Michaeli, DA ;
Plass, DB ;
Schick, DA ;
Melton, ME .
OSTEOPOROSIS INTERNATIONAL, 1997, 7 (05) :444-449
[6]  
Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289
[7]   A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study [J].
Chesnut, CH ;
Silverman, S ;
Andriano, K ;
Genant, H ;
Gimona, A ;
Harris, S ;
Kiel, D ;
LeBoff, M ;
Maricic, M ;
Miller, P ;
Moniz, C ;
Peacock, M ;
Richardson, P ;
Watts, N ;
Baylink, D .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :267-276
[8]   RISK-FACTORS FOR OSTEOPOROSIS [J].
COMPSTON, JE .
CLINICAL ENDOCRINOLOGY, 1992, 36 (03) :223-224
[9]   RADIOGRAPHIC ABSORPTIOMETRY - A SIMPLE METHOD FOR DETERMINATION OF BONE MASS [J].
COSMAN, F ;
HERRINGTON, B ;
HIMMELSTEIN, S ;
LINDSAY, R .
OSTEOPOROSIS INTERNATIONAL, 1991, 2 (01) :34-38
[10]   Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].
Cummings, SR ;
Black, DM ;
Thompson, DE ;
Applegate, WB ;
Barrett-Connor, E ;
Musliner, TA ;
Palermo, L ;
Prineas, R ;
Rubin, SM ;
Scott, JC ;
Vogt, T ;
Wallace, R ;
Yates, AJ ;
LaCroix, AZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082